Médecins sans Frontières (OCG), P.O.Box 325, Mantsholo Road, Mbabane, Eswatini.
Médecins sans Frontières (OCG), Geneva, Switzerland.
BMC Infect Dis. 2024 Aug 15;24(1):829. doi: 10.1186/s12879-024-09744-9.
Improving treatment success rates among multi drug-resistant tuberculosis (MDR-TB) patients is critical to reducing its incidence and mortality, but adherence poses an important challenge. Video-based direct observed therapy (vDOT) may provide adherence benefits, while addressing the time and cost burden associated with community treatment supporter (CTS)-DOT. This study explored experiences of patients, family members and healthcare workers with different DOT modalities for adherence support in Eswatini.
Between April 2021 and May 2022, thirteen men and five women with MDR-TB, ten healthcare workers, and nine caregivers were purposively sampled to include a range of characteristics and experiences with DOT modalities. Data were generated through individual in-depth interviews and a smartphone messaging application (WhatsApp). Data coding was undertaken iteratively, and thematic analysis undertaken, supported by Nvivo.
Four themes emerged that reflected participants' experiences with different DOT modalities, including stigma, efficiency, perceived risks of TB acquisition, and patient autonomy. vDOT was appreciated by patients for providing them with privacy and shielding them from stigmatisation associated with being seen in TB clinics or with community treatment supporters. vDOT was also seen as more efficient than CTS-DOT. Health workers acknowledged that it saved time, allowing them to attend to more patients, while many patients found vDOT more convenient and less expensive by removing the need to travel for in-person consultations. Health workers also appreciated vDOT because it reduced risks of TB acquisition by minimising exposure through virtual patient monitoring. Although many patients appreciated greater autonomy in managing their illness through vDOT, others preferred human contact or struggled with making video recordings. Most family members appreciated vDOT, although some resented feeling removed from the process of supporting loved ones.
vDOT was generally appreciated by MDR-TB patients, their family members and health workers as it addressed barriers to adherence which could contribute to improved treatment completion rates and reduced workplace exposure. However, patients should be offered an alternative to vDOT such as CTS-DOT if this modality does not suit their circumstances or preferences.
提高耐多药结核病(MDR-TB)患者的治疗成功率对于降低其发病率和死亡率至关重要,但坚持治疗是一个重要的挑战。基于视频的直接观察治疗(vDOT)可能会提供坚持治疗的好处,同时解决与社区治疗支持者(CTS)-DOT 相关的时间和成本负担。本研究探讨了斯威士兰不同的直接观察治疗方式在患者、家属和卫生工作者中对坚持治疗的支持作用。
2021 年 4 月至 2022 年 5 月,对 13 名男性和 5 名女性耐多药结核病患者、10 名卫生工作者和 9 名照顾者进行了有针对性的抽样,以纳入不同 DOT 模式的各种特征和经验。通过个人深入访谈和智能手机消息应用程序(WhatsApp)收集数据。通过 Nvivo 进行迭代编码和主题分析。
四个主题反映了参与者对不同 DOT 模式的体验,包括耻辱感、效率、结核病获得的感知风险和患者自主权。vDOT 受到患者的赞赏,因为它为他们提供了隐私,并避免了因在结核病诊所或与社区治疗支持者一起而受到的污名化。vDOT 也被认为比 CTS-DOT 更有效。卫生工作者承认,它节省了时间,使他们能够照顾更多的患者,而许多患者认为 vDOT 更方便,并且通过不需要进行面对面咨询,费用更低。卫生工作者还赞赏 vDOT,因为它通过虚拟患者监测减少了接触传播的风险。尽管许多患者通过 vDOT 更自主地管理自己的疾病,但其他人更喜欢与人接触或难以录制视频。大多数家属都很欣赏 vDOT,但也有人感到被排除在支持亲人的过程之外。
vDOT 普遍受到耐多药结核病患者、家属和卫生工作者的赞赏,因为它解决了坚持治疗的障碍,这可能有助于提高治疗完成率并减少工作场所的暴露。然而,如果该模式不适合患者的情况或偏好,应向患者提供 vDOT 的替代方案,例如 CTS-DOT。